妊娠中にを患う女性:現在のガイドラインの体系的なレビュー
Zhu Liu1, Qiulei Hong1, Luyan Huang1
1Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Epilepsy & behavior : E&B
|August 28, 2025
まとめ
このレビューでは,妊娠中の女性におけるの管理に関する限られた,不一致なガイドラインが示されました. より良い証拠に基づいた勧告のために,より多くの研究と大規模なレジスタが必要です.
科学分野:
- 神経科学
- 産婦人科
- 臨床ガイドライン開発
背景:
- は出産の可能性のある女性に影響します.
- 妊婦 と 胎児 の 両方 に とっ て,妊娠 中 の を 管理 する の は 特別 な 課題 です.
研究 の 目的:
- 妊婦のの管理に関する既存の臨床ガイドラインの質を体系的に評価する.
- これらのガイドラインの主要な勧告を比較する.
主な方法:
- 臨床実務ガイドラインと専門家のコンセンサス声明の体系的なレビュー
- 研究と評価のためのガイドラインの評価II (AGREEII) を用いた品質評価
- 抽出したコア情報の比較分析
主要な成果:
- 14のガイドラインが特定され,そのほとんどは十分な範囲と明確さを持っていたが,証拠の根拠は弱かった.
- 妊娠前のカウンセリング,葉酸,陰道出産,母乳育児,バルプロアート摂取の回避に関する一貫した勧告
- 抗発作薬 (ASM) の選択,薬物モニタリング,および葉酸の用量;新しいASMおよび疼痛管理のギャップに注意された.
結論:
- ガイドラインの変動は,証拠不足と方法論的厳格性の必要性を強調しています.
- 証拠に基づいた改善された勧告が必要である.
- 将来のガイドラインの改善に 大規模な潜在妊娠登録が不可欠です
関連する概念動画
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Seizures: Classification
584
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
584
Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608


